David M. Weber
Net Worth

Last updated:

What is David M. Weber net worth?

The estimated net worth of Dr. David M. Weber is at least $141,964,251 as of 31 Mar 2022. He owns shares worth $44,317,960 as insider, has earned $85,576,611 from insider trading and has received compensation worth at least $12,069,680 in Abiomed, Inc. and Abiomed, Inc..

What is the salary of David M. Weber?

Dr. David M. Weber salary is $754,480 per year as Senior Vice President & Chief Operating Officer in Abiomed, Inc.. He also receives $752,480 as Senior Vice President & Chief Operating Officer in Abiomed, Inc..

How old is David M. Weber?

Dr. David M. Weber is 64 years old, born in 1961.

What stocks does David M. Weber currently own?

As insider, Dr. David M. Weber owns shares in one company:

Company Title Shares Price per share Total value
Abiomed, Inc. (ABMD) Senior Vice President & Chief Operating Officer 116,314 $381.02 $44,317,960

What does Abiomed, Inc. do?

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by interventional cardiologists to support patients in the cath lab, as well as by cardiac surgeons in the heart surgery suite. It also provides Impella 5.0, Impella LD, and Impella 5.5, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; Impella Connect, a cloud-based technology that enables secure and remote viewing of the automated impella controller for physicians and hospital staffs; and OXY-1 System, a portable external respiratory assistance device. In addition, the company is developing Impella ECP, a pump for blood flow of greater than three liters per minute; Impella XR Sheath, a sheath that expands and recoils allowing small bore access and closure with Impella heart pumps; Impella BTR, a percutaneous micro heart pump with integrated motors and sensors; and preCARDIA, a catheter-mounted superior vena cava therapy system designed to rapidly treat acutely decompensated heart failure. Abiomed, Inc. sells its products through direct sales and clinical support personnel in the Germany, France, United States, Japan, Europe, Canada, Latin America, the Asia-Pacific, and the Middle East. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. As of December 22, 2022, Abiomed, Inc. operates as a subsidiary of Johnson & Johnson.

David M. Weber insider trading

Abiomed, Inc.

Dr. David M. Weber has made 54 insider trades between 2010-2022, according to the Form 4 filled with the SEC. Most recently he sold 7,500 units of ABMD stock worth $2,550,000 on 31 Mar 2022.

The largest trade he's ever made was exercising 52,000 units of ABMD stock on 5 May 2016. As of 31 Mar 2022 he still owns at least 116,314 units of ABMD stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock, $.01 par value 7,500 $340 $2,550,000
Sale
Common Stock, $.01 par value 7,500 $325 $2,437,500
Option
Common Stock, $.01 par value 3,112 $21.55 $67,064
Sale
Common Stock, $.01 par value 3,112 $310.19 $965,311
Sale
Common Stock, $.01 par value 4,884 $300.4 $1,467,139
Sale
Common Stock, $.01 par value 1,888 $310 $585,280
Sale
Common Stock, $.01 par value 641 $301.1 $193,003
Option
Common Stock, $.01 par value 7,413 $21.55 $159,750
Sale
Common Stock, $.01 par value 300 $300.25 $90,076
Option
Common Stock, $.01 par value 300 $21.55 $6,465
Sale
Common Stock, $.01 par value 300 $317.88 $95,364
Option
Common Stock, $.01 par value 13,000 $23.15 $300,950
Sale
Common Stock, $.01 par value 12,700 $311.4 $3,954,742
Sale
Common Stock, $.01 par value 12,700 $311.4 $3,954,742
Sale
Common Stock, $.01 par value 12,700 $311.4 $3,954,742
Sale
Common Stock, $.01 par value 8,095 $206.72 $1,673,423
Option
Stock Option (Right to Buy) 4,175 $23.15 $96,651
Option
Common Stock, $.01 par value 4,175 $23.15 $96,651
Option
Stock Option (right to buy) 14,000 $22.44 $314,160
Option
Stock Option (Right to Buy) 10,000 $23.15 $231,500
Sale
Common Stock, $.01 par value 24,000 $351.95 $8,446,704
Option
Common Stock, $.01 par value 24,000 $22.8 $547,080
Option
Common Stock, $.01 par value 11,000 $22.44 $246,840
Option
Stock Option (right to buy) 11,000 $22.44 $246,840
Sale
Common Stock, $.01 par value 19,282 $360.34 $6,948,153
Option
Common Stock, $.01 par value 33,500 $10.03 $336,005
Option
Stock Option (right to buy) 33,500 $10.03 $336,005
Sale
Common Stock, $.01 par value 46,500 $441.87 $20,546,769
Option
Common Stock, $.01 par value 16,500 $10.03 $165,495
Sale
Common Stock, $.01 par value 16,500 $147.63 $2,435,945
Option
Stock Option (right to buy) 16,500 $10.03 $165,495
Sale
Common Stock, $.01 par value 21,250 $131.53 $2,794,928
Option
Common Stock, $.01 par value 21,250 $5.86 $124,525
Option
Stock Options (right to buy) 21,250 $5.86 $124,525
Option
Common Stock, $.01 par value 21,250 $5.86 $124,525
Sale
Common Stock, $.01 par value 21,250 $107.68 $2,288,243
Option
Stock Options (right to buy) 7,250 N/A N/A
Option
Stock Option (right to buy) 14,000 $5.86 $82,040
Option
Stock Options (right to buy) 6,000 N/A N/A
Option
Common Stock, $.01 par value 25,000 $5.86 $146,500
Sale
Common Stock, $.01 par value 25,000 $106.21 $2,655,325
Option
Stock Option (right to buy) 19,000 $5.86 $111,340
Sale
Common Stock, $.01 par value 4,342 $97.21 $422,090
Sale
Common Stock, $.01 par value 5,604 $94.66 $530,497
Sale
Common Stock, $.01 par value 2,145 $93.82 $201,244
Option
Stock Option (right to buy) 40,000 $13.88 $555,200
Option
Common Stock, $.01 par value 52,000 $13.84 $719,680
Sale
Common Stock, $.01 par value 52,000 $95.26 $4,953,312
Sale
Common Stock, $.01 par value 5,235 $90.12 $471,794
Sale
Common Stock, $.01 par value 479 $13.88 $6,649
Option
Common Stock, $.01 par value 479 $13.88 $6,649
Option
Stock Option (right to buy) 479 $13.88 $6,649
Option
Common Stock, $.01 par value 9,410 $85.19 $801,647
Sale
Common Stock, $.01 par value 9,410 $85.19 $801,647
Option
Common Stock, $.01 par value 8,111 $85.21 $691,138
Sale
Common Stock, $.01 par value 8,111 $85.21 $691,138
Option
Stock Option (right to buy) 17,521 $13.88 $243,191
Sale
Common Stock, $.01 par value 13,393 $61.11 $818,419
Sale
Common Stock, $.01 par value 4,575 $60.93 $278,736
Sale
Common Stock, $.01 par value 5,112 $67.74 $346,272
Option
Common Stock, $.01 par value 34,322 $13.88 $476,389
Option
Stock Option (right to buy) 34,322 $13.88 $476,389
Sale
Common Stock, $.01 par value 34,322 $67.1 $2,302,869
Option
Stock Option (right to buy) 25,678 $13.88 $356,411
Sale
Common Stock, $.01 par value 25,678 $71.89 $1,845,914
Option
Common Stock, $.01 par value 25,678 $13.88 $356,411
Sale
Common Stock, $.01 par value 1,605 $74.1 $118,926
Sale
Common Stock, $.01 par value 3,765 $71.08 $267,601
Option
Stock Option (right to buy) 30,000 $13.88 $416,400
Sale
Common Stock, $.01 par value 30,000 $13.88 $416,400
Option
Common Stock, $.01 par value 30,000 $13.88 $416,400
Option
Common Stock, $.01 par value 7,500 $13.88 $104,100
Sale
Common Stock, $.01 par value 19,500 $29 $565,500
Sale
Common Stock, $.01 par value 27,000 $25.22 $680,940
Option
Stock Option (right to buy) 7,500 $13.88 $104,100
Sale
Common Stock, $.01 par value 5,970 $21.21 $126,606
Sale
Common Stock, $.01 par value 4,202 $20.96 $88,087
Sale
Common Stock, $.01 par value 1,425 $20.94 $29,845
Option
Stock Option (right to buy) 6,500 $13.88 $90,220
Sale
Common Stock, $.01 par value 6,500 $13.88 $90,220
Option
Common Stock, $.01 par value 6,500 $13.88 $90,220
Sale
Common Stock, $.01 par value 6,500 $24 $156,000
Sale
Common Stock, $.01 par value 4,400 $23 $101,200
Sale
Common Stock, $.01 par value 7,100 $22.9 $162,611
Sale
Common Stock, $.01 par value 6,519 $21.2 $138,203
Sale
Common Stock, $.01 par value 6,018 $22.18 $133,497
Sale
Common Stock, $.01 par value 989 $21.6 $21,363
Option
Common Stock, $.01 par value 11,000 $13.88 $152,680
Option
Stock Option (right to buy) 11,000 $13.88 $152,680
Sale
Common Stock, $.01 par value 11,000 $13.88 $152,680
Option
Common Stock, $.01 par value 11,000 $13.88 $152,680
Sale
Common Stock, $.01 par value 11,000 $13.88 $152,680
Option
Stock Option (right to buy) 11,000 $13.88 $152,680
Sale
Common Stock, $.01 par value 10,111 $19.18 $193,969
Sale
Common Stock, $.01 par value 1,800 $17 $30,600
Sale
Common Stock, $.01 par value 7,300 $17 $124,100
Sale
Common Stock, $.01 par value 6,132 $17.12 $104,974
Sale
Common Stock, $.01 par value 1,389 $9.1 $12,640

Abiomed key executives

Abiomed, Inc. executives and other stock owners filed with the SEC: